Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tight junction proteins in intestinal cells are multi-component complexes at the apical-lateral border which seal the paracellular space between neighboring epithelial cells. The major integral membrane proteins involved are Occludin, the Claudin family, Junctional adhesion molecules (JAMs), and Tricellulin, with Zonula occludens (ZO) proteins acting as cytoskeletal adaptors. These proteins are essential for maintaining the intestinal barrier, regulating the paracellular passage of ions, water, solutes, and excluding pathogens and antigens. Disruption leads to barrier dysfunction, observed in inflammatory, infectious, and metabolic diseases. Tight junction proteins are dynamically regulated by intracellular signaling pathways and undergo post-translational modifications (especially phosphorylation), which alter their interactions with the cytoskeleton, their localization, and barrier function. Pharmaceutical strategies aim to stabilize or restore their function in disease states.
Stabilization of TJ proteins to reduce pathological permeability. Inhibition of kinase-mediated phosphorylation disrupting TJ assembly (e.g., MLCK inhibitors block MLC phosphorylation, preserve barrier function). Modulation of inflammatory cytokine signaling (inhibition of TNF-α, IFN-γ reduces TJ protein internalization and redistribution). Enhancement of protein expression (e.g., promotion of Occludin/Claudins increases TJ integrity).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tight junction proteins in intestinal cells.